PharVision Advisers’s Viasat VSAT Stock Holding History

PharVision Advisers’s Portfolio VSAT Stock Details VSAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-16,910	Closed	-$176K	–	443
2025 Q1	$176K	Buy	+16,910	New	+$163K	0.24%	214

Other funds holding VSAT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

OCP

OCO Capital Partners New York $408M AUM 141.9% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PharVision Advisers's VSAT Position: Q2 2025 in Review

PharVision Advisers sold out of Viasat (VSAT) in Q2 2025, closing a stake of 16,910 shares — an estimated $176K sold.

PharVision Advisers first reported a position in VSAT in Q1 2025 and held it in 1 quarter. The position peaked at $176K in Q1 2025. 261 funds tracked by Wall St. Rank hold VSAT as of Q2 2025.

PharVision Advisers reported no remaining Viasat position as of Q2 2025 after selling out during the quarter.
PharVision Advisers sold 16,910 Viasat shares in Q2 2025, an estimated $176K.
PharVision Advisers first reported a position in Viasat in Q1 2025 and held it in 1 quarter.
PharVision Advisers's Viasat position peaked at $176K in Q1 2025.
261 funds tracked by Wall St. Rank held Viasat as of Q2 2025.

Based on PharVision Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.